NIH-funded research R01 grant

Understanding how Borrelia burgdorferi causes persistent infections

Official title: Genetic basis for persistence of Borrelia burgdorferi

Funded at Columbia University Health Sciences · NIH-10932249 · Data updated 2026-11-12

This study is looking at why some people still feel unwell after Lyme disease treatment by checking their blood and spinal fluid for clues about the bacteria and the immune system, hoping to find answers that can help those with lingering symptoms.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 20, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$475,701
NIH project number5R01AI178718-02
Project IDNIH-10932249 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Post-Treatment Lyme Disease Syndrome (PTLDS).

Less likely to help

Patients who have not been diagnosed with Lyme disease or those without persistent symptoms may not benefit from this research.

What this research studies

This research investigates the genetic factors that allow the Borrelia burgdorferi bacteria to persist in the body after treatment. By developing advanced assays, the study aims to analyze blood and cerebrospinal fluid samples from patients with Post-Treatment Lyme Disease Syndrome (PTLDS) to identify specific immune responses and potential biomarkers. The approach includes comprehensive serologic analysis and genome assembly of the bacteria in host tissues, which could provide insights into the biology of persistent infections. This research could ultimately help in understanding why some patients continue to experience symptoms after treatment.

Why it matters

Potential benefit: If successful, this research could lead to better diagnostic tools and treatments for patients suffering from lingering symptoms of Lyme disease.

How similar studies have gone: Other research has shown promise in understanding persistent infections in Lyme disease, but this study employs novel assays that have not been widely tested.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Tokarz, Rafal — Columbia University Health Sciences
  • Study coordinator: Tokarz, Rafal

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.